Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17565
Country/Region: Central Asia Region
Year: 2017
Main Partner: Columbia University
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $3,163,000 Additional Pipeline Funding: $150,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $295,000
Laboratory Infrastructure (HLAB) $238,750
Strategic Information (HVSI) $275,000
Testing: HIV Testing and Counseling (HVCT) $120,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $608,692
Treatment: Adult Treatment (HTXS) $1,625,558
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 8,000
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,487
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 765
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 1,520
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 765
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 765
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 765
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 157
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 608
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 384
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 384
HTS_TST Sum of Test Result disaggregates 2018 400
HTS_TST_POS By Test Result: Positive 2018 400
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 150
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 115
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 32
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 19
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2018 320
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2018 467
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2018 207
KP_MAT Sex: Female 2018 31
KP_MAT Sex: Female 2018 37
KP_MAT Sex: Female 2018 52
KP_MAT Sex: Male 2018 289
KP_MAT Sex: Male 2018 430
KP_MAT Sex: Male 2018 155
KP_MAT Sum of Sex Disaggregates 2018 320
KP_MAT Sum of Sex disaggregates 2018 467
KP_MAT Sum of Sex disaggregates 2018 207
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 40
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 60
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 497
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 188
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 537
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 248
TX_CURR Aggregated Age/Sex: 15+ Female 2018 2,041
TX_CURR Aggregated Age/Sex: 15+ Female 2018 1,499
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,110
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,361
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 4,151
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 3,860
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 4,151
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 3,860
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 4,151
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 3,860
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 786
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 834
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,058
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,325
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 1,844
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 2,159
TX_NEW Pregnancy status 2018 113
TX_NEW Pregnancy status 2018 43
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 1,844
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 2,159
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 3,229
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 2,781
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 2,906
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 2,503
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 1,288
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 874
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 142
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 98
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,329
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,378
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 147
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 153
TX_PVLS Numerator: Indication: Routine 2018 2,617
TX_PVLS Numerator: Indication: Routine 2018 2,252
TX_PVLS Numerator: Indication: Targeted 2018 289
TX_PVLS Numerator: Indication: Targeted 2018 251
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 91
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 37
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 12
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 3
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 1,425
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 971
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 159
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 108
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,481
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,532
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 164
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 170
TX_PVLS_den Denominator: Indication: Routine 2018 2,906
TX_PVLS_den Denominator: Indication: Routine 2018 2,503
TX_PVLS_den Denominator: Indication: Targeted 2018 323
TX_PVLS_den Denominator: Indication: Targeted 2018 278
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 102
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 40
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 12
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 3
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 334
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 225
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 442
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 361
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 776
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 586
TX_RET Numerator by Status: Pregnant 2018 45
TX_RET Numerator by Status: Pregnant 2018 10
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 862
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 652
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 372
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 250
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 490
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 402
TX_RET_den Denominator by Status: Pregnant 2018 57
TX_RET_den Denominator by Status: Pregnant 2018 13
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 4,151
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 3,860
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 166
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 155
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 32
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 31
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 134
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 124
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 2,041
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 1,499
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 2,110
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 2,361
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 16
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 14
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 128
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 123
TX_TB_den Denominator: By Screen Result: Negative 2018 3,943
TX_TB_den Denominator: By Screen Result: Negative 2018 3,666
TX_TB_den Denominator: By Screen Result: Positive 2018 208
TX_TB_den Denominator: By Screen Result: Positive 2018 194
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 144
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 137
Cross Cutting Budget Categories and Known Amounts Total: $1
Human Resources for Health $1